ArticleScience translational medicine2021

Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection.

Richard A Urbanowicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.